ロード中...
Immunomodulation Followed by Antigen-Specific T(reg) Infusion Controls Islet Autoimmunity
Optimal immune-based therapies for type 1 diabetes (T1D) should restore self-tolerance without inducing chronic immunosuppression. CD4(+)Foxp3(+) regulatory T cells (T(regs)) are a key cell population capable of facilitating durable immune tolerance. However, clinical trials with expanded T(regs) in...
保存先:
| 出版年: | Diabetes |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6971488/ https://ncbi.nlm.nih.gov/pubmed/31712320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db19-0061 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|